SCHEMBL7671644

SCHEMBL7671644

O=C(N/N=C\c1ccc(Br)cc1)c1[nH]c2ccccc2c1-c1ccc(OC(F)(F)F)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.62
LMNA P02545 6/20 0.62
ALDH1A1 P00352 5/20 0.62
KDM4E B2RXH2 5/20 0.62
SMN1; SMN2 Q16637 3/20 0.62
HPGD P15428 2/20 0.62
RAB9A P51151 1/20 0.62
MEN1 O00255 4/20 0.58
KMT2A Q03164 4/20 0.58
PAX8 Q06710 2/20 0.58
TUBB4A P04350 2/20 0.53
TUBB P07437 2/20 0.53
TUBA3C P0DPH7 2/20 0.53
TUBA1B P68363 2/20 0.53
TUBA4A P68366 2/20 0.53
TUBB4B P68371 2/20 0.53
TUBB3 Q13509 2/20 0.53
TUBB2A Q13885 2/20 0.53
TUBB8 Q3ZCM7 2/20 0.53
TUBA3E Q6PEY2 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7671647 1.00 MAPT (0.62) MAPTLMNAALDH1A1KDM4ESMN1; SMN2
SCHEMBL7561606 0.92 LMNA (0.61) MAPTLMNAALDH1A1KDM4ESMN1; SMN2
SCHEMBL7561610 0.92 LMNA (0.61) MAPTLMNAALDH1A1KDM4ESMN1; SMN2
SCHEMBL7673253 0.91 TUBB4A (0.62) MAPTLMNAALDH1A1KDM4ESMN1; SMN2
SCHEMBL7673248 0.91 TUBB4A (0.62) MAPTLMNAALDH1A1KDM4ESMN1; SMN2
SCHEMBL7560802 0.86 MAPT (0.66) MAPTLMNAALDH1A1KDM4ESMN1; SMN2
SCHEMBL7560806 0.86 MAPT (0.66) MAPTLMNAALDH1A1KDM4ESMN1; SMN2
SCHEMBL7559751 0.86 MAPT (0.78) MAPTLMNAALDH1A1KDM4ESMN1; SMN2
SCHEMBL7559754 0.86 MAPT (0.78) MAPTLMNAALDH1A1KDM4ESMN1; SMN2
SCHEMBL7560613 0.84 MAPT (0.66) MAPTLMNAALDH1A1KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020091148-A1 3-substituted indole antiproliferative angiogenesis inhibitors ABBOTT LABORATORIES 2002-07-11 US claimed
US-20020091148-A1 3-substituted indole antiproliferative angiogenesis inhibitors ABBOTT LABORATORIES 2002-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020091148-A1 3-substituted indole antiproliferative angiogenesis inhibitors MKI67, FLT4, IDO1 MAPT 4828/4885LMNA 4535/4885ALDH1A1 98/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.